See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Liberation Day
Tariffs
Donald Trump
European Union
Nintendo
Trade War
Natural Disasters
Social Media
Trade
FIFA
Artificial Intelligence
Taxes
Published • loading... • Updated

Booster for cellular immunotherapy: Immunologist Michel Sadelain awarded Meyenburg Prize - German Cancer Research CenterLogo des Deutschen KrebsforschungszentrumsLogo of the German Cancer Research CenterLogo of the German Centers for Health ResearchLogo o

Summary by dkfz.de
In 2017, the US Food and Drug Administration (FDA) granted approval for the first time for a completely new treatment for blood cancer in children who could no longer be treated with chemotherapy: they received immunotherapy with their own genetically modified T cells, so-called CAR-T cells. In most patients, the disease responded very well to the treatment – and in many cases, the therapeutic success was permanent, lasting for many years. There
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
dkfz.dedkfz.de

Booster for cellular immunotherapy: Immunologist Michel Sadelain awarded Meyenburg Prize - German Cancer Research CenterLogo des Deutschen KrebsforschungszentrumsLogo of the German Cancer Research CenterLogo of the German Centers for Health ResearchLogo o

In 2017, the US Food and Drug Administration (FDA) granted approval for the first time for a completely new treatment for blood cancer in children who could no longer be treated with chemotherapy: they received immunotherapy with their own genetically modified T cells, so-called CAR-T cells. In most patients, the disease responded very well to the treatment – and in many cases, the therapeutic success was permanent, lasting for many years. There

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

dkfz.de broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

New York State

New York State

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal